Your browser doesn't support javascript.
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.
Reusken, Chantal B E M; Broberg, Eeva K; Haagmans, Bart; Meijer, Adam; Corman, Victor M; Papa, Anna; Charrel, Remi; Drosten, Christian; Koopmans, Marion; Leitmeyer, Katrin.
  • Reusken CBEM; Viroscience department, Erasmus MC, Rotterdam, the Netherlands.
  • Broberg EK; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Haagmans B; European Centre for Disease Prevention and Control, Solna, Sweden.
  • Meijer A; Viroscience department, Erasmus MC, Rotterdam, the Netherlands.
  • Corman VM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Papa A; German Centre for Infection Research (DZIF), Berlin, Germany.
  • Charrel R; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
  • Drosten C; Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Koopmans M; Unité des Virus Emergents (Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
  • Leitmeyer K; German Centre for Infection Research (DZIF), Berlin, Germany.
  • On Behalf Of Evd-LabNet And Erli-Net; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
Euro Surveill ; 25(6)2020 02.
Article in English | MEDLINE | ID: covidwho-664
ABSTRACT
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Clinical Laboratory Techniques / Reverse Transcriptase Polymerase Chain Reaction / Betacoronavirus / Laboratories Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.ES.2020.25.6.2000082

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Clinical Laboratory Techniques / Reverse Transcriptase Polymerase Chain Reaction / Betacoronavirus / Laboratories Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.ES.2020.25.6.2000082